mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.05 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.05 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.05 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
0.31 |
0.05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.05 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.05 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.05 |